Steven Cohen Veru Inc. Transaction History

Point72 Asset Management, L.P.

  • $36.6 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
SELL
$0.98 - $1.49 $11,470 - $17,440
-11,705 Reduced 74.17%
4,076 $4,000
Q1 2023

May 15, 2023
SELL
$1.16 - $6.41 $107,206 - $592,405
-92,419 Reduced 85.41%
15,781 $18,000
Q4 2022

Feb 14, 2023
BUY
$4.78 - $15.01 $517,196 - $1.62 Million
108,200 New
108,200 $571,000

Others Institutions Holding VERU

# of Institutions
123
Shares Held
56.9M
Call Options Held
668K
Put Options Held
531K
View Full List

About VERU INC.

VERU Quotes by TradingView
  • Ticker VERU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,146,704
  • Market Cap $56.9M
  • Description
  • Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....
More about VERU
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email